Trial
NCT05239663
GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
Chemotherapy-Related Cognitive Impairment
Intervention
Ganglioside-Monosialic Acid
Why stopped
Difficulty accruing subjects the study accrual was closed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-01